However, with regard to CNS drug discovery, figures from 1994–2001 show that CNS drugs entering clinical development have a considerably lower probability of reaching the marketplace (7% ...

This not only makes eradication of the virus very difficult but also increases the risk of viral mutation, leading to drug resistance and treatment failure. One of these sites is the CNS.

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid ...

About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic ...

An affidavit obtained by the American-Statesman reveals more details about the 17-car crash and the man accused of causing it ...

CNS Pharmaceuticals expects to report primary ... Additionally, the Company has received Orphan Drug Designation from the FDA for using Berubicin to treat malignant glioma, which may provide ...

Get Instant Summarized Text (Gist) The combination of prescribed stimulants and opioids is linked to increased opioid doses, potentially contributing to a "twin epidemic" of drug use. Analysis of ...

CNS Pharmaceuticals (CNSP) will present at the 6th Glioblastoma Drug Development Summit being held February 18-20, 2025 in Boston, MA. As part of the event, Sandra Silberman, MD, PhD, Chief ...